New England Journal of Medicine最新文献

筛选
英文 中文
Hairy-Cell Leukemia.
IF 96.2 1区 医学
New England Journal of Medicine Pub Date : 2024-12-19 DOI: 10.1056/NEJMc2414034
Ilana Reinhold, Oliver A Cornely, Jannik Stemler
{"title":"Hairy-Cell Leukemia.","authors":"Ilana Reinhold, Oliver A Cornely, Jannik Stemler","doi":"10.1056/NEJMc2414034","DOIUrl":"https://doi.org/10.1056/NEJMc2414034","url":null,"abstract":"","PeriodicalId":54725,"journal":{"name":"New England Journal of Medicine","volume":"391 24","pages":"2386-2387"},"PeriodicalIF":96.2,"publicationDate":"2024-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142857045","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Face to Face - A Neurologist's Perspective on Teleeducation.
IF 96.2 1区 医学
New England Journal of Medicine Pub Date : 2024-12-19 Epub Date: 2024-12-14 DOI: 10.1056/NEJMp2408924
Matthew W Schelke
{"title":"Face to Face - A Neurologist's Perspective on Teleeducation.","authors":"Matthew W Schelke","doi":"10.1056/NEJMp2408924","DOIUrl":"10.1056/NEJMp2408924","url":null,"abstract":"","PeriodicalId":54725,"journal":{"name":"New England Journal of Medicine","volume":" ","pages":"2286-2287"},"PeriodicalIF":96.2,"publicationDate":"2024-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142840155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Myelodysplasia after Lentiviral Gene Therapy.
IF 96.2 1区 医学
New England Journal of Medicine Pub Date : 2024-12-19 DOI: 10.1056/NEJMc2414069
Howard Lopes Ribeiro
{"title":"Myelodysplasia after Lentiviral Gene Therapy.","authors":"Howard Lopes Ribeiro","doi":"10.1056/NEJMc2414069","DOIUrl":"https://doi.org/10.1056/NEJMc2414069","url":null,"abstract":"","PeriodicalId":54725,"journal":{"name":"New England Journal of Medicine","volume":"391 24","pages":"2383-2384"},"PeriodicalIF":96.2,"publicationDate":"2024-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142857053","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Independent Physician Associations - A Bulwark against Corporate Control?
IF 96.2 1区 医学
New England Journal of Medicine Pub Date : 2024-12-19 Epub Date: 2024-12-14 DOI: 10.1056/NEJMp2406792
Jane M Zhu, Deep Shah, Erin Fuse Brown
{"title":"Independent Physician Associations - A Bulwark against Corporate Control?","authors":"Jane M Zhu, Deep Shah, Erin Fuse Brown","doi":"10.1056/NEJMp2406792","DOIUrl":"10.1056/NEJMp2406792","url":null,"abstract":"","PeriodicalId":54725,"journal":{"name":"New England Journal of Medicine","volume":" ","pages":"2283-2285"},"PeriodicalIF":96.2,"publicationDate":"2024-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142840217","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hairy-Cell Leukemia.
IF 96.2 1区 医学
New England Journal of Medicine Pub Date : 2024-12-19 DOI: 10.1056/NEJMc2414034
David J Hermel, Alan Saven
{"title":"Hairy-Cell Leukemia.","authors":"David J Hermel, Alan Saven","doi":"10.1056/NEJMc2414034","DOIUrl":"https://doi.org/10.1056/NEJMc2414034","url":null,"abstract":"","PeriodicalId":54725,"journal":{"name":"New England Journal of Medicine","volume":"391 24","pages":"2387-2388"},"PeriodicalIF":96.2,"publicationDate":"2024-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142857044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Levofloxacin Preventive Therapy for Persons Exposed to MDR Tuberculosis.
IF 96.2 1区 医学
New England Journal of Medicine Pub Date : 2024-12-19 DOI: 10.1056/NEJMe2413531
Susan E Dorman
{"title":"Levofloxacin Preventive Therapy for Persons Exposed to MDR Tuberculosis.","authors":"Susan E Dorman","doi":"10.1056/NEJMe2413531","DOIUrl":"https://doi.org/10.1056/NEJMe2413531","url":null,"abstract":"","PeriodicalId":54725,"journal":{"name":"New England Journal of Medicine","volume":"391 24","pages":"2376-2378"},"PeriodicalIF":96.2,"publicationDate":"2024-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142857048","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype. 嗜酸性粒细胞表型重症哮喘患者一年两次使用地普莫单抗
IF 96.2 1区 医学
New England Journal of Medicine Pub Date : 2024-12-19 Epub Date: 2024-09-09 DOI: 10.1056/NEJMoa2406673
David J Jackson, Michael E Wechsler, Daniel J Jackson, David Bernstein, Stephanie Korn, Paul E Pfeffer, Ruchong Chen, Junpei Saito, Gustavo de Luíz Martinez, Lucyna Dymek, Loretta Jacques, Nicholas Bird, Stein Schalkwijk, Douglas Smith, Peter Howarth, Ian D Pavord
{"title":"Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype.","authors":"David J Jackson, Michael E Wechsler, Daniel J Jackson, David Bernstein, Stephanie Korn, Paul E Pfeffer, Ruchong Chen, Junpei Saito, Gustavo de Luíz Martinez, Lucyna Dymek, Loretta Jacques, Nicholas Bird, Stein Schalkwijk, Douglas Smith, Peter Howarth, Ian D Pavord","doi":"10.1056/NEJMoa2406673","DOIUrl":"10.1056/NEJMoa2406673","url":null,"abstract":"<p><strong>Background: </strong>Depemokimab is an ultra-long-acting biologic therapy with enhanced binding affinity for interleukin-5 that may enable effective 6-month dosing intervals.</p><p><strong>Methods: </strong>In these phase 3A, randomized, placebo-controlled replicate trials, we evaluated the efficacy and safety of depemokimab in patients with severe asthma and an eosinophilic phenotype characterized by a high eosinophil count (≥300 cells per microliter in the previous 12 months or ≥150 cells per microliter at screening) and a history of exacerbations despite the receipt of medium- or high-dose inhaled glucocorticoids. Patients were randomly assigned in a 2:1 ratio to receive either depemokimab (at a dose of 100 mg subcutaneously) or placebo at weeks 0 and 26, plus standard care. The primary end point was the annualized rate of exacerbations at 52 weeks. Secondary end points, which were analyzed in a hierarchical manner to adjust for multiplicity, included the change from baseline in the score on the St. George's Respiratory Questionnaire (SGRQ), the forced expiratory volume in 1 second, and asthma symptom reports at 52 weeks.</p><p><strong>Results: </strong>Across the two trials, 792 patients underwent randomization and 762 were included in the full analysis; 502 were assigned to receive depemokimab and 260 to receive placebo. The annualized rate of exacerbations was 0.46 (95% confidence interval [CI]), 0.36 to 0.58) with depemokimab and 1.11 (95% CI, 0.86 to 1.43) with placebo (rate ratio, 0.42; 95% CI, 0.30 to 0.59; P<0.001) in SWIFT-1 and 0.56 (95% CI, 0.44 to 0.70) with depemokimab and 1.08 (95% CI, 0.83 to 1.41) with placebo (rate ratio, 0.52; 95% CI, 0.36 to 0.73; P<0.001) in SWIFT-2. No significant between-group difference in the change from baseline in the SGRQ score was observed in either trial, so no statistical inference was drawn on subsequent secondary end points. The proportion of patients with any adverse event was similar in the two groups in both trials.</p><p><strong>Conclusions: </strong>Depemokimab reduced the annualized rate of exacerbations among patients with severe asthma with an eosinophilic phenotype. (Funded by GSK; SWIFT-1 and SWIFT-2 ClinicalTrials.gov numbers, NCT04719832 and NCT04718103.).</p>","PeriodicalId":54725,"journal":{"name":"New England Journal of Medicine","volume":" ","pages":"2337-2349"},"PeriodicalIF":96.2,"publicationDate":"2024-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142156726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Providing Effective Medical Care to Autistic People.
IF 96.2 1区 医学
New England Journal of Medicine Pub Date : 2024-12-19 Epub Date: 2024-12-14 DOI: 10.1056/NEJMp2407467
Lauren D Schiff, Ashley O D Hester, Teal Benevides
{"title":"Providing Effective Medical Care to Autistic People.","authors":"Lauren D Schiff, Ashley O D Hester, Teal Benevides","doi":"10.1056/NEJMp2407467","DOIUrl":"10.1056/NEJMp2407467","url":null,"abstract":"","PeriodicalId":54725,"journal":{"name":"New England Journal of Medicine","volume":" ","pages":"2281-2283"},"PeriodicalIF":96.2,"publicationDate":"2024-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142840247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Case 40-2024: A 56-Year-Old Woman with End-Stage Liver Disease and Headache.
IF 96.2 1区 医学
New England Journal of Medicine Pub Date : 2024-12-19 DOI: 10.1056/NEJMcpc2402504
Shoshana J Herzig, Benjamin M Kozak, Camille N Kotton, Annemarie E Fogerty, Sarah E Turbett
{"title":"Case 40-2024: A 56-Year-Old Woman with End-Stage Liver Disease and Headache.","authors":"Shoshana J Herzig, Benjamin M Kozak, Camille N Kotton, Annemarie E Fogerty, Sarah E Turbett","doi":"10.1056/NEJMcpc2402504","DOIUrl":"https://doi.org/10.1056/NEJMcpc2402504","url":null,"abstract":"","PeriodicalId":54725,"journal":{"name":"New England Journal of Medicine","volume":"391 24","pages":"2361-2369"},"PeriodicalIF":96.2,"publicationDate":"2024-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142857017","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chest Radiography for Presumed Pneumonia in Children.
IF 96.2 1区 医学
New England Journal of Medicine Pub Date : 2024-12-19 DOI: 10.1056/NEJMclde2408146
Julie R Barzilay, Mark I Neuman, Todd A Florin
{"title":"Chest Radiography for Presumed Pneumonia in Children.","authors":"Julie R Barzilay, Mark I Neuman, Todd A Florin","doi":"10.1056/NEJMclde2408146","DOIUrl":"https://doi.org/10.1056/NEJMclde2408146","url":null,"abstract":"","PeriodicalId":54725,"journal":{"name":"New England Journal of Medicine","volume":"391 24","pages":"2379-2381"},"PeriodicalIF":96.2,"publicationDate":"2024-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142857038","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信